ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 154,10
0,28%
Dow Jones
39 056,39
0,00%
DAX
18 656,33
0,91%
Brent Oil
83,745
0,22%
Bitcoin
61 432,08
0,40%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cara Therapeutics Inc (CARA)

  7. Cara Therapeutics Inc (CARA) Actualités

CARA

Cara Therapeutics (CARA)

Cara Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CARA
DateHeureSourceTitreSymboleSociété
06/05/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
06/05/202413h00GlobeNewswire Inc.Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:CARACara Therapeutics Inc
02/04/202413h00GlobeNewswire Inc.Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CARACara Therapeutics Inc
07/03/202413h00GlobeNewswire Inc.Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024NASDAQ:CARACara Therapeutics Inc
06/03/202422h45Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CARACara Therapeutics Inc
04/03/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
04/03/202422h01GlobeNewswire Inc.Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CARACara Therapeutics Inc
14/02/202400h50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CARACara Therapeutics Inc
12/02/202422h01GlobeNewswire Inc.Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024NASDAQ:CARACara Therapeutics Inc
22/01/202413h00GlobeNewswire Inc.Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026NASDAQ:CARACara Therapeutics Inc
18/12/202313h00GlobeNewswire Inc.Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic DermatitisNASDAQ:CARACara Therapeutics Inc
13/11/202322h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CARACara Therapeutics Inc
13/11/202322h01GlobeNewswire Inc.Cara Therapeutics Reports Third Quarter 2023 Financial ResultsNASDAQ:CARACara Therapeutics Inc
02/11/202312h00GlobeNewswire Inc.Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare RoyaltyNASDAQ:CARACara Therapeutics Inc
23/10/202313h00GlobeNewswire Inc.Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023NASDAQ:CARACara Therapeutics Inc
25/09/202313h00GlobeNewswire Inc.Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis PatientsNASDAQ:CARACara Therapeutics Inc
05/09/202313h00GlobeNewswire Inc.Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:CARACara Therapeutics Inc
07/08/202322h01GlobeNewswire Inc.Cara Therapeutics Reports Second Quarter 2023 Financial ResultsNASDAQ:CARACara Therapeutics Inc
04/08/202323h19Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
03/08/202313h00GlobeNewswire Inc.Cara Therapeutics Appoints Helen M. Boudreau to Board of DirectorsNASDAQ:CARACara Therapeutics Inc
02/08/202313h00GlobeNewswire Inc.Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:CARACara Therapeutics Inc
24/07/202313h00GlobeNewswire Inc.Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023NASDAQ:CARACara Therapeutics Inc
27/06/202322h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CARACara Therapeutics Inc
03/06/202300h46PR Newswire (US)Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:CARACara Therapeutics Inc
02/06/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CARACara Therapeutics Inc
01/06/202313h00GlobeNewswire Inc.Cara Therapeutics to Present at the Jefferies Healthcare ConferenceNASDAQ:CARACara Therapeutics Inc
18/05/202308h00PR Newswire (US)Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritusNASDAQ:CARACara Therapeutics Inc
18/05/202308h00GlobeNewswire Inc.Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritusNASDAQ:CARACara Therapeutics Inc
15/05/202322h01GlobeNewswire Inc.Cara Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:CARACara Therapeutics Inc
01/05/202313h00GlobeNewswire Inc.Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023NASDAQ:CARACara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CARA

Dernières Valeurs Consultées

EU
VK
Vallourec
NASDAQ
GOOGL
Alphabet
EU
ACA
Credit Agricole
NYSE
DIS
Walt Disney
EU
DG
Vinci
EU
VIV
Vivendi
EU
CS
Axa
EU
RNO
Renault
EU
LR
Legrand
NYSE
MRK
Merck
EU
BN
Danone
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés